Patents Assigned to InNexus Biotechnology Internaltional Ltd.
  • Publication number: 20090208418
    Abstract: Superantibodies having enhanced autophilic, catalytic, and/or membrane-penetrating properties are prepared by affinity-based conjugation of a photoactivatable organic molecule to a target immunoglobulin. The photoactivatable organic molecule bears a chromophoric aromatic hydrocarbon moiety, which has affinity for the immunoglobulin. Upon photolysis, the organic molecule is covalently linked to the immunoglobulin. A preferred organic molecule is a peptide and a preferred aromatic hydrocarbon moiety is a tryptophan residue. The photoactivatable organic molecule need not bear a purine, pyrimidine or azido group to effect binding to the immunoglobulin and/or photoactivation. The superantibodies can enhance the potency and expand the targeting range of target antibodies. Autophilic superantibodies can promote apoptosis of target cells and/or enhance therapeutic efficacies in the treatment of patients with diseases or disorders responsive to antibody therapy.
    Type: Application
    Filed: April 29, 2005
    Publication date: August 20, 2009
    Applicant: InNexus Biotechnology Internaltional Ltd.
    Inventors: Heinz Kohler, Sybille Muller, Alton C. Morgan Jr.